182 related articles for article (PubMed ID: 35155394)
1. Dual Functionalized
Zahirović A; Plavec TV; Berlec A
Front Bioeng Biotechnol; 2022; 10():822823. PubMed ID: 35155394
[TBL] [Abstract][Full Text] [Related]
2. Secretion and surface display of binders of IL-23/IL-17 cytokines and their receptors in Lactococcus lactis as a therapeutic approach against inflammation.
Plavec TV; Klemenčič K; Kuchař M; Malý P; Berlec A
Eur J Pharm Sci; 2023 Nov; 190():106568. PubMed ID: 37619953
[TBL] [Abstract][Full Text] [Related]
3. Targeting of fluorescent Lactococcus lactis to colorectal cancer cells through surface display of tumour-antigen binding proteins.
Plavec TV; Mitrović A; Perišić Nanut M; Štrukelj B; Kos J; Berlec A
Microb Biotechnol; 2021 Sep; 14(5):2227-2240. PubMed ID: 34347360
[TBL] [Abstract][Full Text] [Related]
4. Targeting IL-6 by engineered Lactococcus lactis via surface-displayed affibody.
Zahirović A; Berlec A
Microb Cell Fact; 2022 Jul; 21(1):143. PubMed ID: 35842694
[TBL] [Abstract][Full Text] [Related]
5. Lactic Acid Bacteria with Concomitant IL-17, IL-23 and TNFα- Binding Ability for the Treatment of Inflammatory Bowel Disease.
Kosler S; Strukelj B; Berlec A
Curr Pharm Biotechnol; 2017; 18(4):318-326. PubMed ID: 28190384
[TBL] [Abstract][Full Text] [Related]
6. Evasin-displaying lactic acid bacteria bind different chemokines and neutralize CXCL8 production in Caco-2 cells.
Škrlec K; Pucer Janež A; Rogelj B; Štrukelj B; Berlec A
Microb Biotechnol; 2017 Nov; 10(6):1732-1743. PubMed ID: 28736998
[TBL] [Abstract][Full Text] [Related]
7. Engineered
Plavec TV; Kuchař M; Benko A; Lišková V; Černý J; Berlec A; Malý P
Microorganisms; 2019 May; 7(5):. PubMed ID: 31137908
[No Abstract] [Full Text] [Related]
8. Lectin-Mediated Binding of Engineered
Plavec TV; Zahirović A; Zadravec P; Sabotič J; Berlec A
Microorganisms; 2021 Jan; 9(2):. PubMed ID: 33499141
[TBL] [Abstract][Full Text] [Related]
9. Human Soluble TRAIL Secreted by Modified
Kaczmarek K; Więckiewicz J; Que I; Gałuszka-Bulaga A; Chan A; Siedlar M; Baran J
Arch Immunol Ther Exp (Warsz); 2024 Jan; 72(1):. PubMed ID: 38299562
[TBL] [Abstract][Full Text] [Related]
10. Secretion of tumoricidal human tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) by recombinant Lactococcus lactis: optimization of in vitro synthesis conditions.
Ciaćma K; Więckiewicz J; Kędracka-Krok S; Kurtyka M; Stec M; Siedlar M; Baran J
Microb Cell Fact; 2018 Nov; 17(1):177. PubMed ID: 30446013
[TBL] [Abstract][Full Text] [Related]
11. p19-Targeting ILP Protein Blockers of IL-23/Th-17 Pro-Inflammatory Axis Displayed on Engineered Bacteria of Food Origin.
Škrlec K; Zadravec P; Hlavničková M; Kuchař M; Vaňková L; Petroková H; Křížová L; Černý J; Berlec A; Malý P
Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 29966384
[TBL] [Abstract][Full Text] [Related]
12. Effects in the use of a genetically engineered strain of Lactococcus lactis delivering in situ IL-10 as a therapy to treat low-grade colon inflammation.
Martín R; Chain F; Miquel S; Natividad JM; Sokol H; Verdu EF; Langella P; Bermúdez-Humarán LG
Hum Vaccin Immunother; 2014; 10(6):1611-21. PubMed ID: 24732667
[TBL] [Abstract][Full Text] [Related]
13. Anti-tumoral Effects of Recombinant
Jacouton E; Torres Maravilla E; Boucard AS; Pouderous N; Pessoa Vilela AP; Naas I; Chain F; Azevedo V; Langella P; Bermúdez-Humarán LG
Front Microbiol; 2018; 9():3355. PubMed ID: 30728820
[TBL] [Abstract][Full Text] [Related]
14. Probiotic Activity of Enterococcus faecium and Lactococcus lactis Isolated from Thai Fermented Sausages and Their Protective Effect Against Clostridium difficile.
Dowdell P; Chankhamhaengdecha S; Panbangred W; Janvilisri T; Aroonnual A
Probiotics Antimicrob Proteins; 2020 Jun; 12(2):641-648. PubMed ID: 30888623
[TBL] [Abstract][Full Text] [Related]
15. Recombinant invasive Lactococcus lactis can transfer DNA vaccines either directly to dendritic cells or across an epithelial cell monolayer.
de Azevedo M; Meijerink M; Taverne N; Pereira VB; LeBlanc JG; Azevedo V; Miyoshi A; Langella P; Wells JM; Chatel JM
Vaccine; 2015 Sep; 33(38):4807-12. PubMed ID: 26241952
[TBL] [Abstract][Full Text] [Related]
16. Cell surface display system for Lactococcus lactis: a novel development for oral vaccine.
Raha AR; Varma NR; Yusoff K; Ross E; Foo HL
Appl Microbiol Biotechnol; 2005 Jul; 68(1):75-81. PubMed ID: 15635459
[TBL] [Abstract][Full Text] [Related]
17. Secretion of biologically active human interleukin 22 (IL-22) by Lactococcus lactis.
Loera-Arias MJ; Villatoro-Hernández J; Parga-Castillo MA; Salcido-Montenegro A; Barboza-Quintana O; Muñoz-Maldonado GE; Montes-de-Oca-Luna R; Saucedo-Cárdenas O
Biotechnol Lett; 2014 Dec; 36(12):2489-94. PubMed ID: 25214209
[TBL] [Abstract][Full Text] [Related]
18. Engineered and wild-type L. lactis promote anti-inflammatory cytokine signalling in inflammatory bowel disease patient's mucosa.
Simčič S; Berlec A; Stopinšek S; Štrukelj B; Orel R
World J Microbiol Biotechnol; 2019 Feb; 35(3):45. PubMed ID: 30810891
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of Salmonella Virulence Gene Expression During Invasion of Epithelial Cells Treated with Lactococcus lactis subsp. cremoris JFR1 Requires OppA.
Zhang JS; Corredig M; Morales-Rayas R; Hassan A; Griffiths MW; LaPointe G
Probiotics Antimicrob Proteins; 2020 Jun; 12(2):577-588. PubMed ID: 31377945
[TBL] [Abstract][Full Text] [Related]
20. Expression of biologically active murine interleukin-18 in Lactococcus lactis.
Feizollahzadeh S; Khanahmad H; Rahimmanesh I; Ganjalikhani-Hakemi M; Andalib A; Sanei MH; Rezaei A
FEMS Microbiol Lett; 2016 Nov; 363(21):. PubMed ID: 27864297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
